BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26137913)

  • 1. Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.
    Cui D; Zhang C; Liu B; Shu Y; Du T; Shu D; Wang K; Dai F; Liu Y; Li C; Pan F; Yang Y; Ni J; Li H; Brand-Saberi B; Guo P
    Sci Rep; 2015 Jul; 5():10726. PubMed ID: 26137913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer.
    Wang K; Ruan J; Qian Q; Song H; Bao C; Zhang X; Kong Y; Zhang C; Hu G; Ni J; Cui D
    J Nanobiotechnology; 2011 May; 9():23. PubMed ID: 21612621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
    Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
    Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
    Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
    Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
    Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
    RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.
    Yao H; Sun L; Li J; Zhou X; Li R; Shao R; Zhang Y; Li L
    Int J Nanomedicine; 2020; 15():7013-7034. PubMed ID: 33061365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.
    Fan C; Liu J; Tian J; Zhang Y; Yan M; Zhu C
    Cytogenet Genome Res; 2018; 154(4):209-216. PubMed ID: 29902801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo.
    Chen Y; Lian G; Liao C; Wang W; Zeng L; Qian C; Huang K; Shuai X
    J Gastroenterol; 2013 Jul; 48(7):809-21. PubMed ID: 23179610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGr1-Ag/37LRP promotes growth and proliferation of gastric cancer in vitro and in vivo.
    Liu L; Sun L; Wu K; Shi Y; Wang Y; Wang Y; Zhang N; Zhang H; Zhang H
    Cancer Gene Ther; 2014 Sep; 21(9):355-63. PubMed ID: 25060631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
    Chen H; Chen L; Sun L; Zhen H; Li X; Zhang Q
    Gastric Cancer; 2011 Oct; 14(4):339-52. PubMed ID: 21538018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
    Chen Y; Sun L; Guo D; Wu Z; Chen W
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo.
    Yuan W; Chen Z; Chen Z; Wu S; Guo J; Ge J; Yang P; Huang J
    Neoplasma; 2012; 59(1):105-13. PubMed ID: 22103904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse.
    Akhtar J; Wang Z; Yu C; Zhang ZP
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1685-91. PubMed ID: 24720379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lentiviral vector-mediated Nanog short-hairpin RNA inhibits the growth of human gastric carcinoma xenograft in nude mice].
    Li K; Jiang Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):18-22. PubMed ID: 25575052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression.
    Xu Y; Pang L; Wang H; Xu C; Shah H; Guo P; Shu D; Qian SY
    Redox Biol; 2019 Feb; 21():101085. PubMed ID: 30584980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the proliferation of human gastric cancer cells SGC-7901 in vitro and in vivo using Bcl-2 siRNA.
    Hao JH; Gu QL; Liu BY; Li JF; Chen XH; Ji YB; Zhu ZG; Lin YZ
    Chin Med J (Engl); 2007 Dec; 120(23):2105-11. PubMed ID: 18167184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
    Guo S; Tschammer N; Mohammed S; Guo P
    Hum Gene Ther; 2005 Sep; 16(9):1097-109. PubMed ID: 16149908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.